REGN Earning Date, Earning Analysis and Earning Prediction

Quarterly Results

REGN Earnings Forecast

Looking ahead, REGN remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q1 project quarter revenue of 3.42B and an EPS of 10.48.

However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been revised upward by 0.05%, while EPS estimates have been revised downward by -0.11%. For the upcoming Q4 2025, revenue estimates have been adjusted unchanged by 0%. These revisions correlate with a 6.34% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in REGN long-term fundamentals.

The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

RevenueEPS

Currency: USD

Revenue Estimate-:0

EPS Estimate-:0

—

Stock Price0

Revenue Estimates for FY2025

Revise Upward

+0.05%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.11%

In Past 3 Month

Revenue Estimates for Q4 2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+6.34%

In Past 3 Month

Earnings Forecast

Revenue

EPS

Currency: USD

Actual

Estimate

AI Analysis

Earnings Surprise Analysis

Revenue

EPS

AI Analysis

Earnings Reaction

The chart below shows how REGN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, REGN sees a -0.67% change in stock price 10 days leading up to the earnings, and a 1.62% change 10 days following the report. On the earnings day itself, the stock moves by 0.89%. This data can give you a slight idea of what to expect for the next quarter's release.

For example, in DEC/2025, the stock changed 1.83% on the day following the earnings release and then changed by 8.32% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

People Also Watch

Frequently Asked Questions

What were the key highlights of REGN's latest earnings report for ?

REGN reported its earnings on 2026-01-30, showcasing a revenue of 3.88B against an estimate of 3.82B, resulting in a 1.68% surprise. The EPS was 11.44, surpassing the expected 10.6 by 7.92%. The stock experienced a -1.07% price change on the earnings day and a 3.42% change over the next five days, reflecting market reactions to the results.

How did REGN's stock price react after the earnings release?

Following REGN's earnings announcement on 2026-01-30, the stock price moved by -1.07% on the day of the release. Over the subsequent five days, it saw a 3.42% change. Historically, REGN's stock price tends to shift by an average of -0.67% in the 10 days leading up to earnings and 1.62% in the 10 days following, providing insight into potential market.

What are the revenue and EPS estimates for REGN for 2026/Q1?

For 2026/Q1, analysts estimate REGN's annual revenue to reach 3.42B, while the EPS is projected at 10.48. These estimates reflect recent revisions, with revenue estimates revised upward by 0.05% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

How does REGN's stock price correlate with earnings forecast revisions?

The correlation between REGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.05%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

What should investors expect from REGN's next earnings report?

Based on historical trends, REGN's stock price typically moves by -0.67% in the 10 days before its earnings and 1.62% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 10.48 and revenue of 3.42B.

What is the sentiment in Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Summary?

The earnings call summary highlighted strong growth prospects for key products like Dupixent and EYLEA HD, along with robust financial metrics such as $4.1 billion in free cash flow and $3.8 billion returned to shareholders. Despite some unclear responses in the Q&A, the pipeline expansion and optimistic guidance on new product developments suggest positive momentum. The company's strategic focus on innovative therapies and shareholder returns further supports a positive outlook for the stock price over the next two weeks.